Showing results (11-20 of 57) with videos related to
Sort By:
Pageof 6
Canadian Journal of Physiology and Pharmacology|September 9, 2017
Female offspring born to obese and insulin-resistant dams are not at increased risk for obesity and metabolic dysfunction during early developmentHanin Aburasayn, Rami Al Batran, Keshav Gopal, et al.Canadian Journal of Physiology and Pharmacology|December 1, 2021
The anti-anginal ranolazine does not confer beneficial actions against hepatic steatosis in male mice subjected to high-fat diet and streptozotocin-induced type 2 diabetesChristina T Saed, Amanda A Greenwell, Seyed Amirhossein Tabatabaei Dakhili, et al.Cellular Signalling|December 3, 2013
β-Catenin, a Sox2 binding partner, regulates the DNA binding and transcriptional activity of Sox2 in breast cancer cellsXiaoxia Ye, Fang Wu, Chengsheng Wu, et al.Science Translational Medicine|February 8, 2019
Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicityBruno Saleme, Vikram Gurtu, Yongneng Zhang, et al.Journal of Cardiovascular Pharmacology|July 16, 2019
Role of Cytochrome p450 and Soluble Epoxide Hydrolase Enzymes and Their Associated Metabolites in the Pathogenesis of Diabetic CardiomyopathyZaid H Maayah, Erica McGinn, Rami Al Batran, et al.Journal of Cardiovascular Pharmacology|June 26, 2026
Effect of EET-A treatment on Cardiac Hypertrophy Induced by Isoproterenol in Sprague-Dawley RatsSara A Helal, Samar H Gerges, Keshav Gopal, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 5, 2026
Aryl hydrocarbon receptor ligand 6-formylindolo[3,2-b]carbazole attenuates pressure overload cardiac hypertrophy by activating the CYP1A1/19(S)-hydroxyeicosatetraenoic acid (HETE) and suppressing midchain-HETEs/G protein coupled receptor 31 pathwaysAhmad H Alammari, Shereen M Hamza, Fadumo Ahmed Isse, et al.Bioinformation|October 28, 2010
Identification and modeling of a drug target for Clostridium perfringens SM101Gagan Chhabra, Pramila Sharma, Avishek Anant, et al.European Journal of Medicinal Chemistry|October 18, 2020
SP1-independent inhibition of FOXM1 by modified thiazolidinedionesSeyed Amirhossein Tabatabaei Dakhili, David J Pérez, Keshav Gopal, et al.Bioorganic Chemistry|October 27, 2019
A structure-activity relationship study of Forkhead Domain Inhibitors (FDI): The importance of halogen binding interactionsSeyed Amirhossein Tabatabaei Dakhili, David J Pérez, Keshav Gopal, et al.Pageof 6